nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—CYP1A2—Carmustine—malignant glioma	0.119	0.57	CbGbCtD
Progesterone—CYP3A4—Temozolomide—malignant glioma	0.0902	0.431	CbGbCtD
Progesterone—Infertility—Carmustine—malignant glioma	0.0098	0.0278	CcSEcCtD
Progesterone—Infertility—Temozolomide—malignant glioma	0.00947	0.0269	CcSEcCtD
Progesterone—Clotting—Temozolomide—malignant glioma	0.00692	0.0196	CcSEcCtD
Progesterone—Personality disorder—Carmustine—malignant glioma	0.00591	0.0168	CcSEcCtD
Progesterone—Disorder sight—Temozolomide—malignant glioma	0.00519	0.0147	CcSEcCtD
Progesterone—Transient ischaemic attack—Temozolomide—malignant glioma	0.0049	0.0139	CcSEcCtD
Progesterone—Transaminases increased—Carmustine—malignant glioma	0.0042	0.0119	CcSEcCtD
Progesterone—Cerebration impaired—Temozolomide—malignant glioma	0.0042	0.0119	CcSEcCtD
Progesterone—Embolism—Temozolomide—malignant glioma	0.00385	0.0109	CcSEcCtD
Progesterone—Tooth disorder—Temozolomide—malignant glioma	0.00381	0.0108	CcSEcCtD
Progesterone—Digestion impaired—Temozolomide—malignant glioma	0.0037	0.0105	CcSEcCtD
Progesterone—Thrombosis—Carmustine—malignant glioma	0.00361	0.0103	CcSEcCtD
Progesterone—Myopathy—Temozolomide—malignant glioma	0.00352	0.01	CcSEcCtD
Progesterone—Influenza-like symptoms—Temozolomide—malignant glioma	0.00346	0.00982	CcSEcCtD
Progesterone—Stupor—Carmustine—malignant glioma	0.00343	0.00972	CcSEcCtD
Progesterone—PGR—blood vessel—malignant glioma	0.00336	0.0405	CbGeAlD
Progesterone—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00334	0.00948	CcSEcCtD
Progesterone—Menorrhagia—Temozolomide—malignant glioma	0.00334	0.00948	CcSEcCtD
Progesterone—Cholestasis—Temozolomide—malignant glioma	0.00326	0.00924	CcSEcCtD
Progesterone—Abscess—Carmustine—malignant glioma	0.00323	0.00917	CcSEcCtD
Progesterone—Coagulopathy—Temozolomide—malignant glioma	0.00318	0.00901	CcSEcCtD
Progesterone—Memory impairment—Temozolomide—malignant glioma	0.00315	0.00894	CcSEcCtD
Progesterone—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.003	0.00853	CcSEcCtD
Progesterone—Endocrine disorder—Temozolomide—malignant glioma	0.00298	0.00846	CcSEcCtD
Progesterone—Speech disorder—Carmustine—malignant glioma	0.00297	0.00844	CcSEcCtD
Progesterone—Accidental injury—Carmustine—malignant glioma	0.00289	0.0082	CcSEcCtD
Progesterone—Speech disorder—Temozolomide—malignant glioma	0.00287	0.00816	CcSEcCtD
Progesterone—Disturbance in attention—Temozolomide—malignant glioma	0.00285	0.0081	CcSEcCtD
Progesterone—Breast pain—Temozolomide—malignant glioma	0.00283	0.00804	CcSEcCtD
Progesterone—Amenorrhoea—Temozolomide—malignant glioma	0.00281	0.00798	CcSEcCtD
Progesterone—Drug interaction—Carmustine—malignant glioma	0.00276	0.00782	CcSEcCtD
Progesterone—Viral infection—Temozolomide—malignant glioma	0.00274	0.00777	CcSEcCtD
Progesterone—Herpes simplex—Temozolomide—malignant glioma	0.00268	0.00761	CcSEcCtD
Progesterone—ESR1—blood vessel—malignant glioma	0.00263	0.0317	CbGeAlD
Progesterone—Gait disturbance—Carmustine—malignant glioma	0.00262	0.00744	CcSEcCtD
Progesterone—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00261	0.00742	CcSEcCtD
Progesterone—Pulmonary embolism—Carmustine—malignant glioma	0.00256	0.00726	CcSEcCtD
Progesterone—Gait disturbance—Temozolomide—malignant glioma	0.00253	0.00719	CcSEcCtD
Progesterone—Musculoskeletal pain—Temozolomide—malignant glioma	0.0025	0.0071	CcSEcCtD
Progesterone—Pulmonary embolism—Temozolomide—malignant glioma	0.00247	0.00701	CcSEcCtD
Progesterone—Vaginal inflammation—Temozolomide—malignant glioma	0.00247	0.00701	CcSEcCtD
Progesterone—Depressed level of consciousness—Carmustine—malignant glioma	0.00247	0.00701	CcSEcCtD
Progesterone—Influenza like illness—Temozolomide—malignant glioma	0.0024	0.00681	CcSEcCtD
Progesterone—Depressed level of consciousness—Temozolomide—malignant glioma	0.00239	0.00677	CcSEcCtD
Progesterone—Vaginal infection—Temozolomide—malignant glioma	0.00233	0.00662	CcSEcCtD
Progesterone—Neoplasm—Carmustine—malignant glioma	0.00231	0.00656	CcSEcCtD
Progesterone—Neoplasm—Temozolomide—malignant glioma	0.00223	0.00634	CcSEcCtD
Progesterone—Abnormal vision—Carmustine—malignant glioma	0.00223	0.00633	CcSEcCtD
Progesterone—Mental disability—Carmustine—malignant glioma	0.00222	0.0063	CcSEcCtD
Progesterone—Abnormal vision—Temozolomide—malignant glioma	0.00216	0.00612	CcSEcCtD
Progesterone—Mental disability—Temozolomide—malignant glioma	0.00215	0.00609	CcSEcCtD
Progesterone—Thrombophlebitis—Carmustine—malignant glioma	0.00214	0.00609	CcSEcCtD
Progesterone—Swelling—Carmustine—malignant glioma	0.0021	0.00597	CcSEcCtD
Progesterone—Ear pain—Temozolomide—malignant glioma	0.0021	0.00597	CcSEcCtD
Progesterone—Thrombophlebitis—Temozolomide—malignant glioma	0.00207	0.00588	CcSEcCtD
Progesterone—SHBG—brainstem—malignant glioma	0.00204	0.0246	CbGeAlD
Progesterone—Gastroenteritis—Temozolomide—malignant glioma	0.00202	0.00574	CcSEcCtD
Progesterone—Injury—Carmustine—malignant glioma	0.00202	0.00573	CcSEcCtD
Progesterone—Vascular purpura—Temozolomide—malignant glioma	0.00201	0.00569	CcSEcCtD
Progesterone—Hepatic failure—Temozolomide—malignant glioma	0.002	0.00567	CcSEcCtD
Progesterone—NR3C2—brainstem—malignant glioma	0.00198	0.0238	CbGeAlD
Progesterone—Nasal congestion—Temozolomide—malignant glioma	0.00197	0.00559	CcSEcCtD
Progesterone—Hot flush—Temozolomide—malignant glioma	0.00192	0.00544	CcSEcCtD
Progesterone—CYP17A1—medulla oblongata—malignant glioma	0.00191	0.023	CbGeAlD
Progesterone—NR3C2—retina—malignant glioma	0.00191	0.023	CbGeAlD
Progesterone—Menopausal symptoms—Temozolomide—malignant glioma	0.0019	0.0054	CcSEcCtD
Progesterone—Thirst—Temozolomide—malignant glioma	0.00189	0.00535	CcSEcCtD
Progesterone—Purpura—Temozolomide—malignant glioma	0.00186	0.00528	CcSEcCtD
Progesterone—Diplopia—Carmustine—malignant glioma	0.00186	0.00527	CcSEcCtD
Progesterone—SLC22A3—embryo—malignant glioma	0.00183	0.0221	CbGeAlD
Progesterone—Diplopia—Temozolomide—malignant glioma	0.00179	0.00509	CcSEcCtD
Progesterone—Face oedema—Carmustine—malignant glioma	0.00179	0.00509	CcSEcCtD
Progesterone—Affect lability—Temozolomide—malignant glioma	0.00177	0.00501	CcSEcCtD
Progesterone—NR3C2—telencephalon—malignant glioma	0.00175	0.0212	CbGeAlD
Progesterone—Face oedema—Temozolomide—malignant glioma	0.00173	0.00492	CcSEcCtD
Progesterone—Liver function test abnormal—Carmustine—malignant glioma	0.00171	0.00486	CcSEcCtD
Progesterone—Mood swings—Temozolomide—malignant glioma	0.0017	0.00482	CcSEcCtD
Progesterone—Breast disorder—Temozolomide—malignant glioma	0.00162	0.0046	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00162	0.00459	CcSEcCtD
Progesterone—Dysphagia—Carmustine—malignant glioma	0.0016	0.00455	CcSEcCtD
Progesterone—SLC10A1—central nervous system—malignant glioma	0.00158	0.0191	CbGeAlD
Progesterone—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00158	0.00449	CcSEcCtD
Progesterone—ESR1—embryo—malignant glioma	0.00157	0.0189	CbGeAlD
Progesterone—Abdominal distension—Temozolomide—malignant glioma	0.00156	0.00443	CcSEcCtD
Progesterone—SLC22A1—telencephalon—malignant glioma	0.00156	0.0188	CbGeAlD
Progesterone—Dysphagia—Temozolomide—malignant glioma	0.00155	0.0044	CcSEcCtD
Progesterone—Sweating increased—Temozolomide—malignant glioma	0.00151	0.00429	CcSEcCtD
Progesterone—Bronchitis—Temozolomide—malignant glioma	0.00149	0.00423	CcSEcCtD
Progesterone—Dysuria—Temozolomide—malignant glioma	0.00145	0.00412	CcSEcCtD
Progesterone—Hyperglycaemia—Carmustine—malignant glioma	0.00145	0.00411	CcSEcCtD
Progesterone—SIGMAR1—telencephalon—malignant glioma	0.00144	0.0174	CbGeAlD
Progesterone—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00144	0.00409	CcSEcCtD
Progesterone—Pneumonia—Carmustine—malignant glioma	0.00144	0.00408	CcSEcCtD
Progesterone—ESR1—brainstem—malignant glioma	0.00144	0.0173	CbGeAlD
Progesterone—Pollakiuria—Temozolomide—malignant glioma	0.00143	0.00407	CcSEcCtD
Progesterone—Depression—Carmustine—malignant glioma	0.00143	0.00405	CcSEcCtD
Progesterone—Weight increased—Temozolomide—malignant glioma	0.00141	0.00401	CcSEcCtD
Progesterone—Weight decreased—Temozolomide—malignant glioma	0.0014	0.00398	CcSEcCtD
Progesterone—Neuropathy peripheral—Carmustine—malignant glioma	0.0014	0.00398	CcSEcCtD
Progesterone—Hyperglycaemia—Temozolomide—malignant glioma	0.0014	0.00397	CcSEcCtD
Progesterone—OPRK1—central nervous system—malignant glioma	0.00139	0.0168	CbGeAlD
Progesterone—Urinary tract infection—Carmustine—malignant glioma	0.00139	0.00395	CcSEcCtD
Progesterone—Pneumonia—Temozolomide—malignant glioma	0.00139	0.00395	CcSEcCtD
Progesterone—Infestation—Temozolomide—malignant glioma	0.00138	0.00392	CcSEcCtD
Progesterone—Infestation NOS—Temozolomide—malignant glioma	0.00138	0.00392	CcSEcCtD
Progesterone—CYP17A1—central nervous system—malignant glioma	0.00138	0.0166	CbGeAlD
Progesterone—Depression—Temozolomide—malignant glioma	0.00138	0.00391	CcSEcCtD
Progesterone—NR3C2—medulla oblongata—malignant glioma	0.00138	0.0166	CbGeAlD
Progesterone—CYP1B1—telencephalon—malignant glioma	0.00137	0.0165	CbGeAlD
Progesterone—OPRK1—cerebellum—malignant glioma	0.00136	0.0165	CbGeAlD
Progesterone—Neuropathy peripheral—Temozolomide—malignant glioma	0.00136	0.00385	CcSEcCtD
Progesterone—Urinary tract infection—Temozolomide—malignant glioma	0.00134	0.00381	CcSEcCtD
Progesterone—Hepatobiliary disease—Temozolomide—malignant glioma	0.00131	0.00371	CcSEcCtD
Progesterone—AR—telencephalon—malignant glioma	0.0013	0.0157	CbGeAlD
Progesterone—Sinusitis—Temozolomide—malignant glioma	0.0013	0.00368	CcSEcCtD
Progesterone—Haemoglobin—Carmustine—malignant glioma	0.00129	0.00366	CcSEcCtD
Progesterone—Haemorrhage—Carmustine—malignant glioma	0.00128	0.00365	CcSEcCtD
Progesterone—ESR1—telencephalon—malignant glioma	0.00127	0.0154	CbGeAlD
Progesterone—Oedema peripheral—Carmustine—malignant glioma	0.00127	0.00359	CcSEcCtD
Progesterone—Connective tissue disorder—Carmustine—malignant glioma	0.00126	0.00358	CcSEcCtD
Progesterone—NR3C2—midbrain—malignant glioma	0.00126	0.0152	CbGeAlD
Progesterone—SLC10A1—brain—malignant glioma	0.00126	0.0152	CbGeAlD
Progesterone—Haemoglobin—Temozolomide—malignant glioma	0.00125	0.00354	CcSEcCtD
Progesterone—Haemorrhage—Temozolomide—malignant glioma	0.00124	0.00352	CcSEcCtD
Progesterone—Hepatitis—Temozolomide—malignant glioma	0.00124	0.00352	CcSEcCtD
Progesterone—Visual impairment—Carmustine—malignant glioma	0.00124	0.00351	CcSEcCtD
Progesterone—ABCC1—telencephalon—malignant glioma	0.00123	0.0149	CbGeAlD
Progesterone—Pharyngitis—Temozolomide—malignant glioma	0.00123	0.0035	CcSEcCtD
Progesterone—NR3C2—spinal cord—malignant glioma	0.00123	0.0148	CbGeAlD
Progesterone—Urinary tract disorder—Temozolomide—malignant glioma	0.00123	0.00348	CcSEcCtD
Progesterone—Oedema peripheral—Temozolomide—malignant glioma	0.00122	0.00347	CcSEcCtD
Progesterone—Connective tissue disorder—Temozolomide—malignant glioma	0.00122	0.00346	CcSEcCtD
Progesterone—Urethral disorder—Temozolomide—malignant glioma	0.00122	0.00345	CcSEcCtD
Progesterone—Eye disorder—Carmustine—malignant glioma	0.0012	0.00341	CcSEcCtD
Progesterone—Visual impairment—Temozolomide—malignant glioma	0.0012	0.00339	CcSEcCtD
Progesterone—Erythema multiforme—Temozolomide—malignant glioma	0.00117	0.00333	CcSEcCtD
Progesterone—Eye disorder—Temozolomide—malignant glioma	0.00116	0.00329	CcSEcCtD
Progesterone—Tinnitus—Temozolomide—malignant glioma	0.00116	0.00328	CcSEcCtD
Progesterone—NR3C1—embryo—malignant glioma	0.00116	0.014	CbGeAlD
Progesterone—Cardiac disorder—Temozolomide—malignant glioma	0.00115	0.00327	CcSEcCtD
Progesterone—Alopecia—Carmustine—malignant glioma	0.00114	0.00322	CcSEcCtD
Progesterone—SIGMAR1—medulla oblongata—malignant glioma	0.00113	0.0137	CbGeAlD
Progesterone—Angiopathy—Temozolomide—malignant glioma	0.00113	0.0032	CcSEcCtD
Progesterone—Mental disorder—Carmustine—malignant glioma	0.00113	0.00319	CcSEcCtD
Progesterone—Immune system disorder—Temozolomide—malignant glioma	0.00112	0.00318	CcSEcCtD
Progesterone—Mediastinal disorder—Temozolomide—malignant glioma	0.00112	0.00317	CcSEcCtD
Progesterone—Erythema—Carmustine—malignant glioma	0.00112	0.00317	CcSEcCtD
Progesterone—Malnutrition—Carmustine—malignant glioma	0.00112	0.00317	CcSEcCtD
Progesterone—OPRK1—brain—malignant glioma	0.00111	0.0134	CbGeAlD
Progesterone—Alopecia—Temozolomide—malignant glioma	0.0011	0.00311	CcSEcCtD
Progesterone—CYP17A1—brain—malignant glioma	0.0011	0.0132	CbGeAlD
Progesterone—Mental disorder—Temozolomide—malignant glioma	0.00109	0.00309	CcSEcCtD
Progesterone—Back pain—Carmustine—malignant glioma	0.00108	0.00307	CcSEcCtD
Progesterone—Malnutrition—Temozolomide—malignant glioma	0.00108	0.00307	CcSEcCtD
Progesterone—Erythema—Temozolomide—malignant glioma	0.00108	0.00307	CcSEcCtD
Progesterone—NR3C1—brainstem—malignant glioma	0.00106	0.0128	CbGeAlD
Progesterone—Vision blurred—Carmustine—malignant glioma	0.00105	0.00299	CcSEcCtD
Progesterone—Tremor—Carmustine—malignant glioma	0.00105	0.00297	CcSEcCtD
Progesterone—Back pain—Temozolomide—malignant glioma	0.00105	0.00297	CcSEcCtD
Progesterone—CYP2A6—cerebellum—malignant glioma	0.00104	0.0125	CbGeAlD
Progesterone—ABCB1—blood vessel—malignant glioma	0.00104	0.0125	CbGeAlD
Progesterone—SIGMAR1—midbrain—malignant glioma	0.00104	0.0125	CbGeAlD
Progesterone—Anaemia—Carmustine—malignant glioma	0.00103	0.00293	CcSEcCtD
Progesterone—SHBG—central nervous system—malignant glioma	0.00103	0.0124	CbGeAlD
Progesterone—Vision blurred—Temozolomide—malignant glioma	0.00102	0.00289	CcSEcCtD
Progesterone—Tremor—Temozolomide—malignant glioma	0.00101	0.00287	CcSEcCtD
Progesterone—SIGMAR1—spinal cord—malignant glioma	0.00101	0.0122	CbGeAlD
Progesterone—SHBG—cerebellum—malignant glioma	0.00101	0.0121	CbGeAlD
Progesterone—Ill-defined disorder—Temozolomide—malignant glioma	0.001	0.00285	CcSEcCtD
Progesterone—Anaemia—Temozolomide—malignant glioma	0.000999	0.00283	CcSEcCtD
Progesterone—NR3C2—central nervous system—malignant glioma	0.000997	0.012	CbGeAlD
Progesterone—Angioedema—Temozolomide—malignant glioma	0.000987	0.0028	CcSEcCtD
Progesterone—Malaise—Temozolomide—malignant glioma	0.000974	0.00277	CcSEcCtD
Progesterone—NR3C2—cerebellum—malignant glioma	0.000974	0.0118	CbGeAlD
Progesterone—Vertigo—Temozolomide—malignant glioma	0.000971	0.00275	CcSEcCtD
Progesterone—Convulsion—Carmustine—malignant glioma	0.000969	0.00275	CcSEcCtD
Progesterone—Hypertension—Carmustine—malignant glioma	0.000965	0.00274	CcSEcCtD
Progesterone—Palpitations—Temozolomide—malignant glioma	0.000955	0.00271	CcSEcCtD
Progesterone—Chest pain—Carmustine—malignant glioma	0.000952	0.0027	CcSEcCtD
Progesterone—Myalgia—Carmustine—malignant glioma	0.000952	0.0027	CcSEcCtD
Progesterone—Anxiety—Carmustine—malignant glioma	0.000949	0.00269	CcSEcCtD
Progesterone—Cough—Temozolomide—malignant glioma	0.000943	0.00268	CcSEcCtD
Progesterone—NR3C1—telencephalon—malignant glioma	0.00094	0.0114	CbGeAlD
Progesterone—Convulsion—Temozolomide—malignant glioma	0.000936	0.00266	CcSEcCtD
Progesterone—Hypertension—Temozolomide—malignant glioma	0.000933	0.00265	CcSEcCtD
Progesterone—PGR—central nervous system—malignant glioma	0.000926	0.0112	CbGeAlD
Progesterone—Confusional state—Carmustine—malignant glioma	0.00092	0.00261	CcSEcCtD
Progesterone—Arthralgia—Temozolomide—malignant glioma	0.00092	0.00261	CcSEcCtD
Progesterone—Myalgia—Temozolomide—malignant glioma	0.00092	0.00261	CcSEcCtD
Progesterone—Anxiety—Temozolomide—malignant glioma	0.000917	0.0026	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000914	0.00259	CcSEcCtD
Progesterone—Oedema—Carmustine—malignant glioma	0.000913	0.00259	CcSEcCtD
Progesterone—AR—spinal cord—malignant glioma	0.00091	0.011	CbGeAlD
Progesterone—Discomfort—Temozolomide—malignant glioma	0.000909	0.00258	CcSEcCtD
Progesterone—Infection—Carmustine—malignant glioma	0.000907	0.00257	CcSEcCtD
Progesterone—PGR—cerebellum—malignant glioma	0.000905	0.0109	CbGeAlD
Progesterone—Dry mouth—Temozolomide—malignant glioma	0.0009	0.00255	CcSEcCtD
Progesterone—Tachycardia—Carmustine—malignant glioma	0.000891	0.00253	CcSEcCtD
Progesterone—Confusional state—Temozolomide—malignant glioma	0.000889	0.00252	CcSEcCtD
Progesterone—SLC22A1—central nervous system—malignant glioma	0.000887	0.0107	CbGeAlD
Progesterone—Drospirenone—BCHE—malignant glioma	0.000883	0.374	CrCbGaD
Progesterone—Anaphylactic shock—Temozolomide—malignant glioma	0.000882	0.0025	CcSEcCtD
Progesterone—Oedema—Temozolomide—malignant glioma	0.000882	0.0025	CcSEcCtD
Progesterone—Infection—Temozolomide—malignant glioma	0.000876	0.00249	CcSEcCtD
Progesterone—Anorexia—Carmustine—malignant glioma	0.00087	0.00247	CcSEcCtD
Progesterone—Nervous system disorder—Temozolomide—malignant glioma	0.000865	0.00245	CcSEcCtD
Progesterone—Skin disorder—Temozolomide—malignant glioma	0.000857	0.00243	CcSEcCtD
Progesterone—Hypotension—Carmustine—malignant glioma	0.000853	0.00242	CcSEcCtD
Progesterone—Hyperhidrosis—Temozolomide—malignant glioma	0.000853	0.00242	CcSEcCtD
Progesterone—SLC22A3—central nervous system—malignant glioma	0.000848	0.0102	CbGeAlD
Progesterone—CYP2A6—brain—malignant glioma	0.000844	0.0102	CbGeAlD
Progesterone—Anorexia—Temozolomide—malignant glioma	0.000841	0.00239	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000831	0.00236	CcSEcCtD
Progesterone—Insomnia—Carmustine—malignant glioma	0.000825	0.00234	CcSEcCtD
Progesterone—Paraesthesia—Carmustine—malignant glioma	0.000819	0.00233	CcSEcCtD
Progesterone—SHBG—brain—malignant glioma	0.000816	0.00985	CbGeAlD
Progesterone—Dyspnoea—Carmustine—malignant glioma	0.000814	0.00231	CcSEcCtD
Progesterone—Somnolence—Carmustine—malignant glioma	0.000811	0.0023	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000803	0.00228	CcSEcCtD
Progesterone—SIGMAR1—cerebellum—malignant glioma	0.000801	0.00967	CbGeAlD
Progesterone—Insomnia—Temozolomide—malignant glioma	0.000798	0.00226	CcSEcCtD
Progesterone—Decreased appetite—Carmustine—malignant glioma	0.000793	0.00225	CcSEcCtD
Progesterone—Paraesthesia—Temozolomide—malignant glioma	0.000792	0.00225	CcSEcCtD
Progesterone—NR3C2—brain—malignant glioma	0.000791	0.00955	CbGeAlD
Progesterone—CYP2D6—brainstem—malignant glioma	0.000789	0.00952	CbGeAlD
Progesterone—Gastrointestinal disorder—Carmustine—malignant glioma	0.000788	0.00224	CcSEcCtD
Progesterone—Dyspnoea—Temozolomide—malignant glioma	0.000786	0.00223	CcSEcCtD
Progesterone—Somnolence—Temozolomide—malignant glioma	0.000784	0.00222	CcSEcCtD
Progesterone—Constipation—Carmustine—malignant glioma	0.00078	0.00221	CcSEcCtD
Progesterone—Pain—Carmustine—malignant glioma	0.00078	0.00221	CcSEcCtD
Progesterone—CYP1B1—central nervous system—malignant glioma	0.000779	0.00941	CbGeAlD
Progesterone—Dyspepsia—Temozolomide—malignant glioma	0.000776	0.0022	CcSEcCtD
Progesterone—Decreased appetite—Temozolomide—malignant glioma	0.000767	0.00218	CcSEcCtD
Progesterone—CYP1B1—cerebellum—malignant glioma	0.000762	0.00919	CbGeAlD
Progesterone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000761	0.00216	CcSEcCtD
Progesterone—Fatigue—Temozolomide—malignant glioma	0.00076	0.00216	CcSEcCtD
Progesterone—Constipation—Temozolomide—malignant glioma	0.000754	0.00214	CcSEcCtD
Progesterone—Pain—Temozolomide—malignant glioma	0.000754	0.00214	CcSEcCtD
Progesterone—Feeling abnormal—Carmustine—malignant glioma	0.000752	0.00213	CcSEcCtD
Progesterone—Gastrointestinal pain—Carmustine—malignant glioma	0.000746	0.00212	CcSEcCtD
Progesterone—NR3C1—medulla oblongata—malignant glioma	0.000739	0.00892	CbGeAlD
Progesterone—AR—central nervous system—malignant glioma	0.000738	0.00891	CbGeAlD
Progesterone—PGR—brain—malignant glioma	0.000735	0.00888	CbGeAlD
Progesterone—Feeling abnormal—Temozolomide—malignant glioma	0.000727	0.00206	CcSEcCtD
Progesterone—ESR1—central nervous system—malignant glioma	0.000725	0.00874	CbGeAlD
Progesterone—Abdominal pain—Carmustine—malignant glioma	0.000721	0.00205	CcSEcCtD
Progesterone—Body temperature increased—Carmustine—malignant glioma	0.000721	0.00205	CcSEcCtD
Progesterone—Gastrointestinal pain—Temozolomide—malignant glioma	0.000721	0.00205	CcSEcCtD
Progesterone—ESR1—cerebellum—malignant glioma	0.000708	0.00855	CbGeAlD
Progesterone—SLC22A1—brain—malignant glioma	0.000704	0.0085	CbGeAlD
Progesterone—Urticaria—Temozolomide—malignant glioma	0.000701	0.00199	CcSEcCtD
Progesterone—CYP2D6—telencephalon—malignant glioma	0.0007	0.00845	CbGeAlD
Progesterone—Abdominal pain—Temozolomide—malignant glioma	0.000697	0.00198	CcSEcCtD
Progesterone—Body temperature increased—Temozolomide—malignant glioma	0.000697	0.00198	CcSEcCtD
Progesterone—ABCC1—cerebellum—malignant glioma	0.000685	0.00827	CbGeAlD
Progesterone—Methyltestosterone—CYP2B6—malignant glioma	0.000679	0.287	CrCbGaD
Progesterone—NR3C1—midbrain—malignant glioma	0.000675	0.00815	CbGeAlD
Progesterone—SLC22A3—brain—malignant glioma	0.000673	0.00812	CbGeAlD
Progesterone—Hypersensitivity—Carmustine—malignant glioma	0.000672	0.00191	CcSEcCtD
Progesterone—NR3C1—spinal cord—malignant glioma	0.000659	0.00795	CbGeAlD
Progesterone—Asthenia—Carmustine—malignant glioma	0.000655	0.00186	CcSEcCtD
Progesterone—SIGMAR1—brain—malignant glioma	0.000651	0.00785	CbGeAlD
Progesterone—Hypersensitivity—Temozolomide—malignant glioma	0.00065	0.00184	CcSEcCtD
Progesterone—Asthenia—Temozolomide—malignant glioma	0.000633	0.0018	CcSEcCtD
Progesterone—Diarrhoea—Carmustine—malignant glioma	0.000624	0.00177	CcSEcCtD
Progesterone—Pruritus—Temozolomide—malignant glioma	0.000624	0.00177	CcSEcCtD
Progesterone—ABCB1—embryo—malignant glioma	0.000619	0.00747	CbGeAlD
Progesterone—CYP1B1—brain—malignant glioma	0.000619	0.00747	CbGeAlD
Progesterone—Dizziness—Carmustine—malignant glioma	0.000603	0.00171	CcSEcCtD
Progesterone—Diarrhoea—Temozolomide—malignant glioma	0.000603	0.00171	CcSEcCtD
Progesterone—AR—brain—malignant glioma	0.000586	0.00707	CbGeAlD
Progesterone—Dizziness—Temozolomide—malignant glioma	0.000583	0.00165	CcSEcCtD
Progesterone—Vomiting—Carmustine—malignant glioma	0.00058	0.00165	CcSEcCtD
Progesterone—Rash—Carmustine—malignant glioma	0.000575	0.00163	CcSEcCtD
Progesterone—ESR1—brain—malignant glioma	0.000575	0.00694	CbGeAlD
Progesterone—Dermatitis—Carmustine—malignant glioma	0.000575	0.00163	CcSEcCtD
Progesterone—Headache—Carmustine—malignant glioma	0.000572	0.00162	CcSEcCtD
Progesterone—Vomiting—Temozolomide—malignant glioma	0.000561	0.00159	CcSEcCtD
Progesterone—ABCC1—brain—malignant glioma	0.000557	0.00672	CbGeAlD
Progesterone—Rash—Temozolomide—malignant glioma	0.000556	0.00158	CcSEcCtD
Progesterone—Dermatitis—Temozolomide—malignant glioma	0.000556	0.00158	CcSEcCtD
Progesterone—Headache—Temozolomide—malignant glioma	0.000552	0.00157	CcSEcCtD
Progesterone—CYP1A1—central nervous system—malignant glioma	0.000551	0.00665	CbGeAlD
Progesterone—ABCB1—retina—malignant glioma	0.000547	0.00661	CbGeAlD
Progesterone—Nausea—Carmustine—malignant glioma	0.000542	0.00154	CcSEcCtD
Progesterone—NR3C1—central nervous system—malignant glioma	0.000535	0.00645	CbGeAlD
Progesterone—Nausea—Temozolomide—malignant glioma	0.000524	0.00149	CcSEcCtD
Progesterone—NR3C1—cerebellum—malignant glioma	0.000522	0.00631	CbGeAlD
Progesterone—ABCB1—telencephalon—malignant glioma	0.000503	0.00608	CbGeAlD
Progesterone—CYP2C8—brain—malignant glioma	0.000474	0.00572	CbGeAlD
Progesterone—CYP1A1—brain—malignant glioma	0.000437	0.00528	CbGeAlD
Progesterone—NR3C1—brain—malignant glioma	0.000424	0.00512	CbGeAlD
Progesterone—Drospirenone—PTGS2—malignant glioma	0.000407	0.172	CrCbGaD
Progesterone—CYP3A4—central nervous system—malignant glioma	0.000404	0.00488	CbGeAlD
Progesterone—CYP2D6—central nervous system—malignant glioma	0.000398	0.0048	CbGeAlD
Progesterone—ABCB1—medulla oblongata—malignant glioma	0.000396	0.00477	CbGeAlD
Progesterone—Testosterone—CYP2B6—malignant glioma	0.000394	0.167	CrCbGaD
Progesterone—CYP2D6—cerebellum—malignant glioma	0.000389	0.00469	CbGeAlD
Progesterone—ABCB1—midbrain—malignant glioma	0.000362	0.00436	CbGeAlD
Progesterone—ABCB1—spinal cord—malignant glioma	0.000353	0.00426	CbGeAlD
Progesterone—CYP2D6—brain—malignant glioma	0.000316	0.00381	CbGeAlD
Progesterone—ABCB1—central nervous system—malignant glioma	0.000286	0.00345	CbGeAlD
Progesterone—ABCB1—cerebellum—malignant glioma	0.00028	0.00338	CbGeAlD
Progesterone—ABCB1—brain—malignant glioma	0.000227	0.00274	CbGeAlD
Progesterone—ESR1—Signaling Pathways—CAV1—malignant glioma	1.61e-05	4.55e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.6e-05	4.54e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—BCHE—malignant glioma	1.59e-05	4.52e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KDR—malignant glioma	1.59e-05	4.5e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.59e-05	4.5e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.58e-05	4.48e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CG—malignant glioma	1.58e-05	4.48e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.57e-05	4.46e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—IDH1—malignant glioma	1.57e-05	4.46e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTT1—malignant glioma	1.56e-05	4.43e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—NCOR1—malignant glioma	1.56e-05	4.43e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—GSTP1—malignant glioma	1.56e-05	4.42e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.56e-05	4.41e-05	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.55e-05	4.4e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PIK3CA—malignant glioma	1.55e-05	4.38e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTEN—malignant glioma	1.54e-05	4.36e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MDM2—malignant glioma	1.54e-05	4.36e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—RAF1—malignant glioma	1.53e-05	4.35e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—F2—malignant glioma	1.53e-05	4.34e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FN1—malignant glioma	1.53e-05	4.34e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PPARG—malignant glioma	1.53e-05	4.32e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SPHK1—malignant glioma	1.52e-05	4.32e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—ERBB2—malignant glioma	1.52e-05	4.3e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CAT—malignant glioma	1.52e-05	4.3e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—BAD—malignant glioma	1.51e-05	4.28e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PIK3CA—malignant glioma	1.51e-05	4.27e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PPARG—malignant glioma	1.5e-05	4.26e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NOTCH1—malignant glioma	1.5e-05	4.24e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CB—malignant glioma	1.5e-05	4.24e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CD—malignant glioma	1.49e-05	4.23e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.49e-05	4.23e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CB—malignant glioma	1.49e-05	4.23e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—malignant glioma	1.49e-05	4.23e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CD—malignant glioma	1.49e-05	4.22e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.49e-05	4.22e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTGS2—malignant glioma	1.48e-05	4.19e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—STAT3—malignant glioma	1.48e-05	4.19e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.48e-05	4.18e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CD80—malignant glioma	1.47e-05	4.16e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS1—malignant glioma	1.47e-05	4.15e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—APC—malignant glioma	1.46e-05	4.15e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CG—malignant glioma	1.46e-05	4.15e-05	CbGpPWpGaD
Progesterone—PGR—Gene Expression—AKT1—malignant glioma	1.46e-05	4.15e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.46e-05	4.14e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGF—malignant glioma	1.45e-05	4.1e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CB—malignant glioma	1.44e-05	4.09e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCL8—malignant glioma	1.44e-05	4.08e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTPN11—malignant glioma	1.44e-05	4.08e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—NCOR1—malignant glioma	1.43e-05	4.06e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTGS2—malignant glioma	1.43e-05	4.05e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.41e-05	4e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTP1—malignant glioma	1.39e-05	3.94e-05	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AKT1—malignant glioma	1.39e-05	3.94e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CD—malignant glioma	1.39e-05	3.94e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CASP3—malignant glioma	1.38e-05	3.9e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—STAT3—malignant glioma	1.38e-05	3.9e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—BRAF—malignant glioma	1.38e-05	3.9e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL2—malignant glioma	1.38e-05	3.9e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MYC—malignant glioma	1.37e-05	3.89e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CD—malignant glioma	1.37e-05	3.88e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—BCHE—malignant glioma	1.36e-05	3.86e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTP1—malignant glioma	1.36e-05	3.85e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CAT—malignant glioma	1.35e-05	3.84e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CAV1—malignant glioma	1.35e-05	3.82e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.35e-05	3.81e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—malignant glioma	1.34e-05	3.8e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT2—malignant glioma	1.34e-05	3.8e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CAT—malignant glioma	1.32e-05	3.74e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CB—malignant glioma	1.3e-05	3.69e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MMP9—malignant glioma	1.3e-05	3.69e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CB—malignant glioma	1.3e-05	3.68e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTEN—malignant glioma	1.29e-05	3.67e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTGS2—malignant glioma	1.29e-05	3.65e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTEN—malignant glioma	1.29e-05	3.65e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTGS2—malignant glioma	1.29e-05	3.65e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CD—malignant glioma	1.29e-05	3.65e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.29e-05	3.65e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MYC—malignant glioma	1.28e-05	3.63e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTP1—malignant glioma	1.28e-05	3.63e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—NCOR1—malignant glioma	1.28e-05	3.62e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CAV1—malignant glioma	1.27e-05	3.61e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.27e-05	3.61e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—malignant glioma	1.27e-05	3.59e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTP1—malignant glioma	1.27e-05	3.59e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CA—malignant glioma	1.26e-05	3.58e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—malignant glioma	1.26e-05	3.58e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.26e-05	3.57e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—malignant glioma	1.25e-05	3.55e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—NCOR1—malignant glioma	1.25e-05	3.54e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTEN—malignant glioma	1.25e-05	3.53e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CAT—malignant glioma	1.25e-05	3.53e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—malignant glioma	1.24e-05	3.51e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CAT—malignant glioma	1.23e-05	3.5e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FGF2—malignant glioma	1.23e-05	3.49e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—malignant glioma	1.23e-05	3.49e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.23e-05	3.48e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—malignant glioma	1.22e-05	3.46e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.22e-05	3.45e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CB—malignant glioma	1.21e-05	3.43e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—malignant glioma	1.21e-05	3.43e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTT1—malignant glioma	1.21e-05	3.42e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—malignant glioma	1.2e-05	3.4e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CB—malignant glioma	1.19e-05	3.38e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PPARG—malignant glioma	1.19e-05	3.36e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—malignant glioma	1.18e-05	3.35e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—malignant glioma	1.18e-05	3.35e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—NCOR1—malignant glioma	1.18e-05	3.33e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—malignant glioma	1.17e-05	3.31e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CAV1—malignant glioma	1.17e-05	3.31e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—NCOR1—malignant glioma	1.17e-05	3.3e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—malignant glioma	1.17e-05	3.3e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CG—malignant glioma	1.16e-05	3.29e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—malignant glioma	1.16e-05	3.28e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MDM2—malignant glioma	1.15e-05	3.27e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RAF1—malignant glioma	1.15e-05	3.26e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ERBB2—malignant glioma	1.14e-05	3.22e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS1—malignant glioma	1.13e-05	3.2e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—malignant glioma	1.13e-05	3.19e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTEN—malignant glioma	1.12e-05	3.19e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTEN—malignant glioma	1.12e-05	3.18e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CB—malignant glioma	1.12e-05	3.18e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PPARG—malignant glioma	1.12e-05	3.17e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—malignant glioma	1.12e-05	3.16e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.12e-05	3.16e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.1e-05	3.12e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—malignant glioma	1.09e-05	3.08e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTP1—malignant glioma	1.08e-05	3.07e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.08e-05	3.06e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCL8—malignant glioma	1.08e-05	3.05e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—malignant glioma	1.08e-05	3.05e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.06e-05	3.01e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CAT—malignant glioma	1.05e-05	2.99e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—malignant glioma	1.05e-05	2.98e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—BCHE—malignant glioma	1.05e-05	2.98e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTEN—malignant glioma	1.05e-05	2.97e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CAV1—malignant glioma	1.04e-05	2.95e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.04e-05	2.94e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—malignant glioma	1.03e-05	2.92e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—malignant glioma	1.03e-05	2.92e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTEN—malignant glioma	1.03e-05	2.92e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—malignant glioma	1.03e-05	2.92e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PPARG—malignant glioma	1.03e-05	2.91e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.02e-05	2.89e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CAV1—malignant glioma	1.02e-05	2.88e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—NCOR1—malignant glioma	9.96e-06	2.82e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.96e-06	2.82e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—malignant glioma	9.94e-06	2.81e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—malignant glioma	9.89e-06	2.8e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MMP9—malignant glioma	9.75e-06	2.76e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTEN—malignant glioma	9.7e-06	2.75e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CAV1—malignant glioma	9.59e-06	2.72e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—malignant glioma	9.52e-06	2.7e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CAV1—malignant glioma	9.5e-06	2.69e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CG—malignant glioma	9.49e-06	2.69e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CB—malignant glioma	9.41e-06	2.67e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CD—malignant glioma	9.35e-06	2.65e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—malignant glioma	9.32e-06	2.64e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CG—malignant glioma	9.27e-06	2.63e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PPARG—malignant glioma	9.16e-06	2.6e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	9.13e-06	2.59e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—malignant glioma	9.1e-06	2.58e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.08e-06	2.57e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PPARG—malignant glioma	8.94e-06	2.53e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CB—malignant glioma	8.89e-06	2.52e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—malignant glioma	8.88e-06	2.51e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—malignant glioma	8.83e-06	2.5e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—malignant glioma	8.81e-06	2.5e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—malignant glioma	8.8e-06	2.49e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—malignant glioma	8.76e-06	2.48e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CG—malignant glioma	8.73e-06	2.47e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—malignant glioma	8.67e-06	2.46e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CG—malignant glioma	8.66e-06	2.45e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—malignant glioma	8.59e-06	2.43e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—malignant glioma	8.46e-06	2.4e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PPARG—malignant glioma	8.43e-06	2.39e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTP1—malignant glioma	8.37e-06	2.37e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PPARG—malignant glioma	8.35e-06	2.37e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CD—malignant glioma	8.35e-06	2.36e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CB—malignant glioma	8.15e-06	2.31e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CD—malignant glioma	8.15e-06	2.31e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CAT—malignant glioma	8.14e-06	2.31e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTEN—malignant glioma	8.13e-06	2.3e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CAV1—malignant glioma	8.12e-06	2.3e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—malignant glioma	8.08e-06	2.29e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—malignant glioma	8.06e-06	2.28e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—malignant glioma	7.94e-06	2.25e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—malignant glioma	7.92e-06	2.24e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—malignant glioma	7.88e-06	2.23e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.76e-06	2.2e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NCOR1—malignant glioma	7.69e-06	2.18e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTEN—malignant glioma	7.68e-06	2.18e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CD—malignant glioma	7.68e-06	2.17e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CD—malignant glioma	7.61e-06	2.16e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—malignant glioma	7.46e-06	2.11e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—malignant glioma	7.45e-06	2.11e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—malignant glioma	7.43e-06	2.11e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CG—malignant glioma	7.4e-06	2.1e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—malignant glioma	7.38e-06	2.09e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CB—malignant glioma	7.27e-06	2.06e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—malignant glioma	7.27e-06	2.06e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—malignant glioma	7.21e-06	2.04e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—malignant glioma	7.19e-06	2.04e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PPARG—malignant glioma	7.14e-06	2.02e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CB—malignant glioma	7.1e-06	2.01e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTEN—malignant glioma	7.04e-06	2e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—malignant glioma	7.04e-06	1.99e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—malignant glioma	6.84e-06	1.94e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CB—malignant glioma	6.69e-06	1.9e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CB—malignant glioma	6.63e-06	1.88e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—malignant glioma	6.63e-06	1.88e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—malignant glioma	6.62e-06	1.87e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—malignant glioma	6.57e-06	1.86e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CD—malignant glioma	6.5e-06	1.84e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—malignant glioma	6.48e-06	1.84e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—malignant glioma	6.47e-06	1.83e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTEN—malignant glioma	6.29e-06	1.78e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CAV1—malignant glioma	6.27e-06	1.78e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTEN—malignant glioma	6.14e-06	1.74e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—malignant glioma	6.03e-06	1.71e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—malignant glioma	5.94e-06	1.68e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTEN—malignant glioma	5.78e-06	1.64e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—malignant glioma	5.74e-06	1.63e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTEN—malignant glioma	5.73e-06	1.62e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.71e-06	1.62e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CB—malignant glioma	5.67e-06	1.61e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—malignant glioma	5.62e-06	1.59e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—malignant glioma	5.59e-06	1.58e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPARG—malignant glioma	5.51e-06	1.56e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—malignant glioma	5.42e-06	1.54e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CD—malignant glioma	5.02e-06	1.42e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—malignant glioma	4.97e-06	1.41e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTEN—malignant glioma	4.9e-06	1.39e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—malignant glioma	4.69e-06	1.33e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—malignant glioma	4.43e-06	1.26e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—malignant glioma	4.43e-06	1.25e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.37e-06	1.24e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—malignant glioma	4.33e-06	1.23e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—malignant glioma	4.33e-06	1.23e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—malignant glioma	4.08e-06	1.16e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—malignant glioma	4.06e-06	1.15e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—malignant glioma	4.04e-06	1.15e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTEN—malignant glioma	3.78e-06	1.07e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—malignant glioma	3.62e-06	1.03e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—malignant glioma	3.54e-06	1e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—malignant glioma	3.46e-06	9.79e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—malignant glioma	3.33e-06	9.44e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—malignant glioma	3.3e-06	9.36e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—malignant glioma	2.82e-06	8e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.67e-06	7.55e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—malignant glioma	2.18e-06	6.17e-06	CbGpPWpGaD
